ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes
about
sameAs
Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A virusesActivation of anaplastic lymphoma kinase is responsible for hyperphosphorylation of ShcC in neuroblastoma cell linesIdentification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV.Identification of a novel HLA-A 02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene.Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrolVaccination therapy for cutaneous T-cell lymphoma.Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes.ALK a novel lymphoma-associated tumor antigen for vaccination strategies.Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.Immunotherapy of neuroblastoma: present, past and future.Paediatric non-Hodgkin lymphoma - perspectives in translational biologyMobilizing the low-avidity T cell repertoire to kill tumors.Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1).Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8(+) T cell responses in children with NPM-ALK(+) anaplastic large cell lymphoma.Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors.Snail-mediated Cripto-1 repression regulates the cell cycle and epithelial-mesenchymal transition-related gene expression.Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen.Cellular and Molecular Targets of Resveratrol on Lymphoma and Leukemia Cells.Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma.ALK-positive anaplastic large-cell lymphoma: strong T and B anti-tumour responses may cause hypocellular aspects of lymph nodes mimicking inflammatory lesions.Immune escape mechanisms in ALCL.Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications.A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.Non-Canonical Thinking for Targeting ALK-Fusion Onco-Proteins in Lung Cancer.Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.
P2860
Q27658413-22A6BC5C-5ED5-4445-82DF-5B6B7742071CQ28218528-51E5F6FC-7544-4F58-9D9A-23C39702440FQ30951751-0BA9CA0F-CDB1-4104-B1D5-6C746FB8A94EQ33793930-611E010B-170D-47A5-AB11-B47B03C90AF2Q34773094-91921487-3E7D-4D5F-83F3-B0257507DB28Q34870725-B99F4B84-EC2A-4D13-A287-6F732020D6CCQ35015875-7457B7B8-C17E-4C5B-AF1F-8D1D578F9B4FQ35561048-BC954FA5-A878-4147-A03F-08423FCB4D94Q35614635-809CFE9A-2B6B-4787-8873-3EC16839A9A8Q35817394-9ED17DA2-D9DE-4571-AB8F-8B789134CF64Q36453273-6ED3A785-A7FD-4588-A1DB-56F01F75EFE8Q36889143-7E9456E9-3E2E-476D-8A0F-B56BD2349ED9Q36891310-C2FBF26B-D8BB-4AC4-9BF3-10DE7037F01FQ37081609-B1D1F937-1656-416E-A28C-CFC02C7A4788Q38307616-3AF6F146-B88C-4781-9401-D88F5B11D673Q38758254-789D6654-3CFE-4A51-A6A3-8DE5482A3FDDQ38831440-148609B4-796A-4B9D-9F4D-FC9EA9746804Q38885231-2A7FF71E-6ACA-4FF7-A7A7-9C8E93C740A0Q38942201-313BB9D7-06F6-4710-A49F-A42527DCE359Q39336887-3C0E4BF8-A323-46CD-B2AF-E813C1A5659EQ39885468-BAEE01EB-A960-4B6B-A1AF-54355781ABFAQ40551172-D7D59E26-5F66-4321-A725-D28B3187C0BFQ43011113-B998C76F-50A2-499C-A66D-A53F1439BD84Q43105000-C38D9CA0-9D48-4B25-A6CC-AA1B21CB0565Q46783012-1F43128A-193F-46FC-BFC3-DEA1E9D5365DQ46793262-5260CD57-958E-497E-9615-7268C65BEC81Q47141906-0DEA14AB-233D-42E8-936E-6C68493DCF4DQ49837454-A4E34C9F-A1AE-4CAD-B259-7F3901355D2AQ54981113-1046AEA6-2928-4F74-B642-C904D5DD66C8
P2860
ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@ast
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@en
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@nl
type
label
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@ast
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@en
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@nl
prefLabel
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@ast
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@en
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@nl
P2093
P356
P1433
P1476
ALK as a novel lymphoma-associ ...... estricted CD8+ T-cell epitopes
@en
P2093
Addolorata M L Coluccia
Antonio Scardino
Barbara Gallo
Carla Bertazzoli
François A Lemonnier
Konstadinos Kosmatopoulos
P304
P356
10.1182/BLOOD.V99.6.2100
P407
P577
2002-03-15T00:00:00Z